Holen Sie sich die Stockscreener-App
12.73
12.65%
1.43
Handel nachbörslich:
12.59
-0.14
-1.10%
Schlusskurs vom Vortag:
$11.30
Offen:
$11.19
24-Stunden-Volumen:
96,745
Relative Volume:
0.95
Marktkapitalisierung:
$210.53M
Einnahmen:
$3.25M
Nettoeinkommen (Verlust:
$-116.80M
KGV:
-4.1738
EPS:
-3.05
Netto-Cashflow:
$-98.17M
1W Leistung:
+11.08%
1M Leistung:
+18.31%
6M Leistung:
+44.66%
1J Leistung:
-22.00%
1-Tages-Spanne:
$11.19
$12.73
1-Wochen-Bereich:
$11.14
$12.73
52-Wochen-Spanne:
$5.6652
$26.56
Rapt Therapeutics Inc Stock (RAPT) Company Profile
Firmenname
Rapt Therapeutics Inc
Sektor
Branche
Telefon
(650) 489-9000
Adresse
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
Vergleichen Sie RAPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RAPT
Rapt Therapeutics Inc
|
12.73 | 196.30M | 3.25M | -116.80M | -98.17M | -3.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-30 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2025-05-22 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-12-26 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-11-13 | Herabstufung | Stifel | Buy → Hold |
| 2024-11-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-11-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-14 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-05-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-02-22 | Herabstufung | UBS | Buy → Neutral |
| 2024-02-21 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-02-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-21 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-02-20 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-02-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-09-14 | Eingeleitet | Berenberg | Buy |
| 2023-08-09 | Eingeleitet | Stifel | Buy |
| 2023-06-15 | Eingeleitet | Barclays | Overweight |
| 2023-01-04 | Eingeleitet | Guggenheim | Buy |
| 2022-12-01 | Eingeleitet | Goldman | Buy |
| 2022-09-21 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-12-09 | Eingeleitet | JP Morgan | Overweight |
| 2021-08-12 | Eingeleitet | SVB Leerink | Outperform |
| 2021-06-21 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-04-13 | Eingeleitet | ROTH Capital | Buy |
| 2019-11-25 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-11-25 | Eingeleitet | UBS | Buy |
| 2019-11-25 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Rapt Therapeutics Inc Aktie (RAPT) Neueste Nachrichten
Using data models to predict RAPT Therapeutics Inc. stock movement2025 Major Catalysts & Accurate Technical Buy Alerts - Newser
Can RAPT Therapeutics Inc. disrupt its industryMarket Movers & Verified Technical Trade Signals - khodrobank.com
Will RAPT Therapeutics Inc. stock hit new highs in YEAROptions Play & Low Drawdown Investment Strategies - khodrobank.com
Can RAPT Therapeutics Inc. withstand a market correction2025 Earnings Surprises & Technical Analysis for Trade Confirmation - khodrobank.com
Backtesting results for RAPT Therapeutics Inc. trading strategiesPortfolio Value Report & Safe Entry Momentum Tips - Newser
Will RAPT Therapeutics Inc. outperform during market ralliesMarket Performance Recap & High Accuracy Trade Alerts - khodrobank.com
How high can RAPT Therapeutics Inc. stock goJuly 2025 Technicals & Entry Point Strategy Guides - Newser
Will RAPT Therapeutics Inc. continue its uptrend2025 Stock Rankings & Real-Time Volume Triggers - Newser
Volume spikes in RAPT Therapeutics Inc. stock – what they meanQuarterly Trade Summary & Free Verified High Yield Trade Plans - Newser
Ranking RAPT Therapeutics Inc. among high performing stocks via toolsTrade Exit Summary & Entry Point Confirmation Alerts - Newser
Automated trading signals detected on RAPT Therapeutics Inc.2025 Top Gainers & High Yield Stock Recommendations - Newser
Is RAPT Therapeutics Inc. building a consolidation baseJuly 2025 Institutional & Expert Approved Trade Ideas - Newser
Candlestick signals on RAPT Therapeutics Inc. stock today2025 Top Gainers & Community Verified Swing Trade Signals - Newser
Will RAPT Therapeutics Inc. stock go up soonBuy Signal & Verified Swing Trading Watchlists - Newser
Institutional Tools Highlight Unusual Flow in RAPT Therapeutics Inc.July 2025 Weekly Recap & Free Weekly Chart Analysis and Trade Guides - beatles.ru
Using R and stats models for RAPT Therapeutics Inc. forecastingShare Buyback & AI Powered Market Entry Ideas - Newser
How to recover losses in RAPT Therapeutics Inc. stockQuarterly Risk Review & Weekly Top Gainers Trade List - Newser
Key resistance and support levels for RAPT Therapeutics Inc.Market Activity Summary & AI Driven Stock Price Forecasts - Newser
Multi factor analysis applied to RAPT Therapeutics Inc.Trade Risk Report & Community Verified Swing Trade Signals - Newser
Will RAPT Therapeutics Inc. see short term momentumQuarterly Portfolio Review & High Return Trade Guides - Newser
Published on: 2025-09-03 07:07:25 - beatles.ru
How to read the order book for RAPT Therapeutics Inc.Trade Risk Assessment & Long-Term Safe Investment Ideas - Newser
Breakout Watch: Can RAPT Therapeutics Inc. disrupt its industry2025 Trade Ideas & Long-Term Growth Plans - khodrobank.com
Analyzing recovery setups for RAPT Therapeutics Inc. investorsProfit Target & Risk Controlled Swing Alerts - Newser
Measuring RAPT Therapeutics Inc.’s beta against major indicesJuly 2025 Short Interest & Weekly Chart Analysis and Guides - Newser
Price momentum metrics for RAPT Therapeutics Inc. explainedQuarterly Profit Summary & Fast Momentum Entry Tips - Newser
Can RAPT Therapeutics Inc. sustain earnings growthWeekly Trade Analysis & Community Consensus Trade Alerts - khodrobank.com
RAPT Therapeutics Inc. stock momentum explainedIPO Watch & Reliable Breakout Forecasts - Newser
Is RAPT Therapeutics Inc. a play on infrastructure spending2025 Volume Leaders & Safe Entry Zone Tips - khodrobank.com
Will RAPT Therapeutics Inc. outperform tech stocks2025 Support & Resistance & Long Hold Capital Preservation Tips - khodrobank.com
Can RAPT Therapeutics Inc. maintain its current growth rateQuarterly Risk Review & High Conviction Investment Ideas - khodrobank.com
What are RAPT Therapeutics Inc.’s earnings expectations2025 Biggest Moves & Real-Time Market Sentiment Reports - khodrobank.com
Earnings visualization tools for RAPT Therapeutics Inc.Weekly Trade Summary & Consistent Profit Focused Trading Strategies - Newser
Using economic indicators to assess RAPT Therapeutics Inc. potentialQuarterly Growth Report & Safe Investment Capital Preservation Plans - Newser
Chartists Watching For Breakout in RAPT Therapeutics Inc.Weekly Stock Analysis & Consistent Profit Trade Alerts - beatles.ru
Chart based exit strategy for RAPT Therapeutics Inc.Market Growth Review & Safe Swing Trade Setups - Newser
How to forecast RAPT Therapeutics Inc. trends using time seriesWeekly Investment Report & Community Verified Swing Trade Signals - Newser
Reversal indicators forming on RAPT Therapeutics Inc. stock2025 Analyst Calls & Weekly Top Gainers Alerts - Newser
Will earnings trigger a reversal in RAPT Therapeutics Inc.Weekly Market Report & Daily Technical Stock Forecast Reports - Newser
Finanzdaten der Rapt Therapeutics Inc-Aktie (RAPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):